Capital Flow Monitor · Sponsors · CIK 2090797
Neela Therapeutics, Inc.
96 ROBBS HILL ROAD, LUNENBURG, MA, 01462 · 781-929-6094
Other Health Care · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$21.5M
Sold
$13.8M
% sold
64.3%
Investors
21
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | D/A ·current | 506(b) | $21.5M | $13.8M | 64.3% | 21 | EDGAR ↗ |
| 2025-11-24 | D | 506(b) | $13.5M | $12.0M | 88.9% | 17 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- PJ Anand — Executive Officer / Director, LUNENBURG, MA
- Norbert Riedel — Director, LUNENBURG, MA
- Richard Upton — Director, LUNENBURG, MA
- David Donabedian — Director, LUNENBURG, MA
- Edgar D. Jannotta Jr. — Director, LUNENBURG, MA
- Stephen Oesterle — Director, LUNENBURG, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.